Amgen selects Buenos Aires for regional clinical research hub, citing faster procedures

Amgen has chosen Buenos Aires as one of eight global clinical research centers, coordinating trials across Argentina, Mexico, and Colombia. The decision reflects Argentina's streamlined regulatory processes and its strong patient enrollment record, ranking fifth globally in Amgen's studies. This signals growing regional investment in clinical research infrastructure, though the broader impact on local healthcare capacity remains to be seen.